Who has invested in Rgenix?

Novo, Sofinnova Partners are named among the investors backing Rgenix.

Rgenix Funding: $73M Raised, Series C (2017)

Rgenix funding overview

Rgenix is based in New York. Rgenix has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2017. The round record for Rgenix runs through 2017; nothing later has been disclosed. Investors on record include Novo, Sofinnova Partners. 2 distinct backers are named across the disclosed rounds.

Rgenix at a glance

Total raised: $73M
Latest round: Series C
Latest round date: January 2017
Headquarters: New York
Notable investors: Novo, Sofinnova Partners

Frequently asked about Rgenix funding

How much has Rgenix raised?: Rgenix has raised $73M in total disclosed funding across the rounds on record.
Who has invested in Rgenix?: Novo, Sofinnova Partners are named among the investors backing Rgenix.
What was the latest Rgenix funding round?: The most recent disclosed round is a Series C, announced in January 2017.
Where is Rgenix based?: Rgenix is based in New York.
When did Rgenix last raise?: The last disclosed Rgenix round closed in January 2017 at Series C.

Every Rgenix figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New York at a similar stage.

Rgenix Funding: $73M Raised, Series C (2017)

Rgenix funding overview

Rgenix at a glance

Frequently asked about Rgenix funding

Companies related to Rgenix (19)

Browse related funding lists (6)